Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-111512
Filing Date
2024-10-25
Accepted
2024-10-25 17:00:20
Documents
4
Period of Report
2024-11-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2426177-2_def14a.htm DEF 14A 611014
2 GRAPHIC lg_petros-4clr.jpg GRAPHIC 13164
3 GRAPHIC px_24petropxy01pg01-bw.jpg GRAPHIC 268616
4 GRAPHIC px_24petropxy01pg02-bw.jpg GRAPHIC 272874
  Complete submission text file 0001104659-24-111512.txt   1319824
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39752 | Film No.: 241397721
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)